Protagonist Therapeutics
PTGX
#3538
Rank
NZ$4.82 B
Marketcap
$78.61
Share price
-4.88%
Change (1 day)
68.43%
Change (1 year)

EPS for Protagonist Therapeutics (PTGX)

EPS in 2023 (TTM): -$4.39

According to Protagonist Therapeutics 's latest financial reports the company's current EPS (TTM) is -$4.76. In 2022 the company made an earnings per share (EPS) of -$4.62 an increase over its 2021 EPS that were of -$4.80.

EPS history for Protagonist Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.39-4.98%
2022-$4.62-3.7%
2021-$4.8035%
2020-$3.55-33.33%
2019-$5.3374.42%
2018-$3.06-20.74%
2017-$3.86-45.64%
2016-$7.0957.3%
2015-$4.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.87-18.66%๐Ÿ‡บ๐Ÿ‡ธ USA